Resources

3 Resources for

delursan

Subscribe to this listing via:
RSS
Email

BNET Resources

Axcan Pharma Reports Solid Start to Fiscal 2008, With Revenue of $92.9 Million in the First Quarter: Axcan Pharma Inc. (TSX: AXP)(NASDAQ: AXCA) today announced financial results for the first quarter of fiscal 2008. All amounts are in U.S. dollars. "We are very pleased with our financial performance in the first quarter of fiscal 2008, which was primarily due to strong sales in our CARAFATE, CANASA...; Tags: Axcan Pharma Inc., CARAFATE, DELURSAN, LACTEOL, PYLERA; Research articles 2008-01-31
Axcan Pharma Continues its Solid Growth Trend, Closing Fiscal 2007 With Record Annual Revenue of $348.9 Million, a 19.4% Increase Over Fiscal 2006: Axcan Pharma Inc. (TSX: AXP)(NASDAQ: AXCA) today announced fourth quarter and year-end financial results. Axcan's fiscal year 2007 was very successful with strong operating results and cash flows. All amounts are in U.S. dollars. "In line with our accomplishments since the beginning of the year, our fourth quarter performance...; Tags: Axcan Pharma Inc., CANASA, DELURSAN, FDA, LACTEOL, PANZYTRAT, PYLERA, ULTRASE; Research articles 2007-11-29
Axcan Pharma Continues its Solid Growth Trend, Closing Fiscal 2007 With Record Annual Revenue of $348.9 Million, a 19.4% Increase Over Fiscal 2006.(Financial report): MONT-SAINT-HILAIRE, QUEBEC, Nov 29, 2007 Marketwire via COMTEX -- - Fourth quarter revenue of $92.5 million, a 27.9% increase as compared to the same period in fiscal 2006 - Fiscal 2007 revenue of $348.9 million, representing growth of 19.4% compared to fiscal 2006 ...; Tags: Axcan Pharma Inc., CANASA, DELURSAN, FDA, PANZYTRAT, PYLERA Axcan, ULTRASE; Research articles 2007-11-29